By the Planet for the Planet

Novel Microbial Ecology Platform

Harness the power of natural microbial communities and their biological functions in Health, Food, Agriculture, and Climate applications

The Promise

In our planet's ecology, there are around a trillion species of bacteria with an enormous variety of biological and ecological functions.

Today only 1% of these bacteria can be cultured

EcoBiotaX uses advanced AI and novel biological capabilities to discover and construct natural-based microbial communities to address the desired functions in health, food, agriculture, and climate applications

Start Now

Solutions Domain

Health

naural based microbial Companion Therapeutics

Food Tech

Pro/Prebiotics, functional food, nutrition supplements

Industrial & Climate

Microbial natural ecology circular economy .

ecoSat- Deep insights Computational Platform

Our novel AI computational platfrom ( ecoSat ) natural bacterial ecology consortiums are based to address a desired biological function and define best-selected consultation to generate these functions based on the used media characteristics and environmental constraints

Our Ecology Generation biological technology enables EcoBiotaX to extract any type of bacteria based on its function from existing samples and generate the required ecologies

Technology

Leadership Team

Naama Geva-Zatorsky

PhD, Co-Founder

Shay Hilel

Co Founder, CEO

Dean Light

Co Founder,CTO

Head of the Microbiome Lab,The Technion, Rappaport Faculty of Medicine, Technion Integrated Cancer Center.Her research combining systems-biology with microbiology and immunology to study the interactions between gut microbes and the host immune system in health and disease. Her Ph.D from the Weizmann Institute, studying systems-biology of protein dynamics in cancer. Her postdoctoral was at Harvard Medical School, studying gut microbiota-host interactions

Serial entrepreneur with vast experience as founder, senior executive & business manager CEO and Co founder of BrainVu (Acquired in 2018 ). Head of the Alcatel Lucent Digital Multimedia Division (Was Spin-off and acquired by Nantworks in 2014 ). Shay worked both in startups and corporate organizations with a verity of hands-on technology leadership roles

A computational biology & SW architect expert focusing on complex multidisciplinary problems. Prior to BiotaX, Dean was software architect @Technion Data & Knowledge (TDK) Lab - the computer science faculty and developer team lead @Lamm lab - the department of biology , Technion.Dean holds an M.Sc. in Biology and B.Sc. in both Mathematics and Computer Science from the Technion.Dean is a recipient of the 2019 Sherman award for distinguished academic achievement in multidisciplinary research.

Advisory Board / Consulting

Assistant Professor Itai Sharon

Migal - Galilee Research Institute

Head of the Computational Microbiology group at Migal.His research focuses on molecular biology techniques along with advanced computational methods and data science approaches to generate and analyze metagenomics and other data. Currently, research in the lab is focused on human-associated microbes and plant-microbiome interactions.

Assistant Professor Elizabeth Half

MD, Rambam Medial Center

A specialist in gastroenterology and hepatology, Director of the Early Detection and Cancer Prevention Unit at Rambam Medical Center, director of the Hereditary Cancer Clinic and the BRCA Carrier Clinic

Assistant Prof Jennifer McQuade,

MD Oncologist MD Anderson

Jennifer L. McQuade, MD, MS, MA is an Assistant Professor and Physician Scientist in Melanoma Medical Oncology. Her research focuses on how lifestyle factors influence melanoma biology and the anti-tumor immune response with the goal of developing novel strategies to improve outcomes in melanoma.

Nurit Tweezer-Zaks

MD, MBA

Pharmaceutical Industry Innovation expert across all therapeutic areas, Senior director at a global pharma MNC (Sanofi), Chief Medical Officer and Business Development at MediCane, Venture Capitalist and Investments in the life Sciences ( aMoon)
Strong scientific, clinical, and commercial proficiency in Business Development Orientation

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle Feb 8 2021

Illumina, Inc. (NASDAQ: ILMN) has selected nine new genomics companies to join the second global funding cycle of Illumina Accelerator in the U.S. and UK. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the second funding cycle of Illumina Accelerator Cambridge, UK and five companies for the twelfth funding cycle of Illumina Accelerator San Francisco Bay Area. The newest companies to join Illumina Accelerator’s portfolio of genomics startups include: BiotaX Labs LTD, a spinoff from Technion Research and Development Foundation (TRDF) Israel, is harnessing the power of the microbiome to diagnose and provide effective, tailored and safe microbial treatments.

Read more...